Jill Ann Howe
CIK: 0001892397
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Lineage Cell Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Mar 5, 2026LCTX
Lineage Cell Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
1.1M shares- - Mar 10, 2025LCTX
Lineage Cell Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
750K shares- - Nov 26, 2024LCTX
Lineage Cell Therapeutics, Inc.
Purchase(P)Direct15K shares at avg. $0.59$9K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 5, 2026 | LCTX Lineage Cell Therapeutics, Inc. | Award(A) Employee Stock Option (Right to Buy) | 1,050,000 | - | - | Direct |
| Mar 10, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Award(A) Employee Stock Option (Right to Buy) | 750,000 | - | - | Direct |
| Nov 26, 2024 | LCTX Lineage Cell Therapeutics, Inc. | Purchase(P) | 15,000 | $0.59 | $8,850 | Direct |
1-3 of 3 transactions
About Howe Jill Ann
Howe Jill Ann (SEC CIK 0001892397) files insider reports with the SEC as Chief Financial Officer of Lineage Cell Therapeutics, Inc. (LCTX).
Signal8 holds 3 ownership filings by Howe Jill Ann, all Form 4s, filed between Nov 26, 2024 and Mar 6, 2026. Those filings report 3 transactions, from Nov 26, 2024 to Mar 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Howe Jill Ann's filings is in CARLSBAD, CA.
Recent filings by Howe Jill Ann
Other insiders filing for Lineage Cell Therapeutics, Inc. (LCTX)
- Bradsher Neal C, Director
- Jayasuriya Anula, Director
- Mulroy Michael H., Director
- ANDREWS DEBORAH J, Director
- Russell Angus C., Director
- Amin Dipti, Director